Two alternative syntheses of 2-oxaadamantan-5-amine, a novel analog of the clinically approved drug amantadine, are reported. The compound has been tested as an anti-influenza A virus agent and as an NMDA receptor antagonist. While the compound was not antivirally active, it displayed moderate activity as an NMDA receptor antagonist.

Ritter reaction-mediated syntheses of 2-oxaadamantan-5-amine, a novel amantadine analog

Moroni A;
2015

Abstract

Two alternative syntheses of 2-oxaadamantan-5-amine, a novel analog of the clinically approved drug amantadine, are reported. The compound has been tested as an anti-influenza A virus agent and as an NMDA receptor antagonist. While the compound was not antivirally active, it displayed moderate activity as an NMDA receptor antagonist.
2015
Istituto di Biofisica - IBF
Inglese
56
10
1272
1275
http://www.scopus.com/inward/record.url?eid=2-s2.0-84923108696&partnerID=q2rCbXpz
Adamantane
Amantadine
M2 channel
NMDA receptor antagonist
Ritter reaction
7
info:eu-repo/semantics/article
262
Leiva, R; Gazzarrini, S; Esplugas, R; Moroni, A; Naesens, L; Sureda, Fx; Vazquez, S
01 Contributo su Rivista::01.01 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/307994
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? ND
social impact